Delivery Order SPE2DB20D2104-SPE2DB24FU00V
Award Date
5/3/24
Potential Completion Date
5/6/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a pharmaceutical product. The contract has a ceiling value of $11,531.19 and a completion date of February 12, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The total ceiling value of the contract is $3,940.58, with a performance period through April 18, 2023. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,761.74, is for the delivery of 4567117581 RYTARY ER 48.75 MG-195 MG capsules in lots of 100. The contract is a Firm Fixed Price type, with a period of performance through February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,774.34, is for the supply of RYTARY ER 36.25 MG-145 MG capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,018.34 firm-fixed-price delivery order contract, with a completion date of May 6, 2024, is for the supply of RYTARY ER 61.25 MG-245 MG capsules. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024. The contract has a firm fixed price of $2,359.95 and an ultimate completion date of December 31, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used in the treatment of Parkinson's disease. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA Troop Support Medical) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,087.98 and a performance period ending on March 12, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. No set-aside designation was used for this...
This federal contract award, SPE2DB20D3101|SPE2DB24FQUT0, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a pharmaceutical product, with a ceiling value of $9,029.53 and a completion date of November 17, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,203.18, is for the supply of RYTARY ER 48.75 MG-195 MG capsules. The contract has a firm fixed price pricing type and a period of performance through January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,921.60, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 29, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...